Healthy men help track new Drug's journey through the body
NCT ID NCT04634812
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study looked at how a single dose of the experimental drug KBP-5074 is absorbed, broken down, and eliminated in 7 healthy men. Researchers measured radioactivity in blood, urine, and feces to understand the drug's path. The goal was not to treat any disease, but to gather basic information for future studies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
KBP-5074
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Covance Clinical Research Unit Inc.
Madison, Wisconsin, 53704, United States